OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reprogramming natural killer cells for cancer therapy
Kexin Wang, Linqin Wang, Yiyun Wang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2835-2855
Closed Access | Times Cited: 8
Kexin Wang, Linqin Wang, Yiyun Wang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2835-2855
Closed Access | Times Cited: 8
Showing 8 citing articles:
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
Yaozhang Yang, Jing Wang, Yan Zhong, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Yaozhang Yang, Jing Wang, Yan Zhong, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Recent advances in understanding the immune microenvironment in ovarian cancer
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody
Ying Gong, Wilfred T.V. Germeraad, Xu‐Lin Zhang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2711-2727
Open Access | Times Cited: 2
Ying Gong, Wilfred T.V. Germeraad, Xu‐Lin Zhang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2711-2727
Open Access | Times Cited: 2
Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery
Emma McErlean, Helen O. McCarthy
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Emma McErlean, Helen O. McCarthy
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Impact of siRNA-Mediated Cofilin-1 Knockdown and Obesity Associated Microenvironment on the Motility of Natural Killer Cells
Bruno Griesler, Marijke Hölzel, Jana Oswald, et al.
Immunological Investigations (2024) Vol. 53, Iss. 5, pp. 713-729
Open Access
Bruno Griesler, Marijke Hölzel, Jana Oswald, et al.
Immunological Investigations (2024) Vol. 53, Iss. 5, pp. 713-729
Open Access
NK cell based immunotherapy against oral squamous cell carcinoma
Ying Zhang, Jianming Xie, Haoran Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Ying Zhang, Jianming Xie, Haoran Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
